CEO James Grant Conroy sold 49,205 Ross Stores shares on the open market at about $229.48 apiece, leaving him with 134,349 shares.
Ross Stores (ROST) disclosed in a Form 4 filing with the Securities and Exchange Commission that chief executive James Grant Conroy sold 49,205 common shares on the open market on 14 September 2026 at $229.4843 per share, a transaction worth roughly $11.3 million.
Tadaa Technology will supply the AI backbone for a 1,000-acre solar farm feeding a data centre under a 25-year power arrangement, targeting $7.3M in annual revenue.
Alpha Compute has signed definitive agreements for Utica and Marcellus acreage with more than 75 wells, and plans to build a data center on the site.
Palisade Bio can start the Phase 2 ASCENTRA-CD trial of its oral PDE4 prodrug, with first dosing targeted for Q1 2027 and a primary readout in Q1 2028.
VERSATILE-002 results for PDS0101 plus pembrolizumab show 39.3 months median overall survival in checkpoint-inhibitor-naive HPV16-positive head and neck cancer.
